Codexis, a shell Oil-backed developer of biocatalysts for biofuel and pharma applications, will see its quiet period end on Monday, May 31st. On April 21st, the company raised $78 million by offering 6 million shares at $13, at the low end of its range of $13-$15. Credit Suisse acted as lead manager on the deal.
